Evidence map›Paper›PMID 31202491›Full record

ArticleBiological psychiatry2019

Neonatal Nicotine Exposure Primes Midbrain Neurons to a Dopaminergic Phenotype and Increases Adult Drug Consumption.

Benedetto Romoli, Adrian F Lozada, Ivette M Sandoval, Fredric P Manfredsson, Thomas S Hnasko, Darwin K Berg, Davide Dulcis

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Biological psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. How the brain produces generalized fear.Clinical and translational medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Benedetto RomoliDepartment of Psychiatry, University of California San Diego, La Jolla, California.
Adrian F LozadaDepartment of Neurobiology, University of California San Diego, La Jolla, California.
Ivette M SandovalDepartment of Translational Science and Molecular Medicine, Michigan State University, East Lansing, Michigan.
Fredric P ManfredssonDepartment of Translational Science and Molecular Medicine, Michigan State University, East Lansing, Michigan.
Thomas S HnaskoDepartment of Neuroscience, University of California San Diego, La Jolla, California; Research Service, Veterans Affairs San Diego Healthcare System, San Diego, California.
Darwin K BergDepartment of Neurobiology, University of California San Diego, La Jolla, California.
Davide DulcisDepartment of Psychiatry, University of California San Diego, La Jolla, California. Electronic address: ddulcis@ucsd.edu.
University of California San Diego · USMichigan State University · US

Funding

Role of novel VTA neurons in addiction-related behaviorsR01DA036612 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Thomas Hnasko · 2014 to 2026
$5.6M
Striatal Nurr1 activity facilitates the dyskinetic state: A novel therapeutic targetR21NS098079 · NINDS · MICHIGAN STATE UNIVERSITY · PI MANFREDSSON, FREDRIC · 2016 to 2017
$441k
Functional significance of dopamine plasticity induced by neonatal nicotine exposure affecting adult drug preferenceR21DA047455 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DULCIS, DAVIDE · 2020 to 2021
$423k
A Girls-Specific Prevention Program for Substance Use and DelinquencyR21DA037455 · NIDA · UNIVERSITY OF WASHINGTON · PI WALKER, SARAH CUSWORTH · 2015 to 2016
$351k
Neurophysiological Characterization of Novel Neurotensin Receptor Ligands to Define Therapeutic Potential in Combatting AddictionI01BX003759 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI HNASKO, THOMAS · 2018 to 2022
–
BLRD VA I01 BX003759NIDA NIH HHS R01 DA036612NIDA NIH HHS R21 DA037455NIDA NIH HHS R21 DA047455NINDS NIH HHS R21 NS098079
6 · The paper itself

Abstract

backgroundNicotine intake induces addiction through neuroplasticity of the reward circuitry, altering the activity of dopaminergic neurons of the ventral tegmental area. Prior work demonstrated that altered circuit activity can change neurotransmitter expression in the developing and adult brain. Here we investigated the effects of neonatal nicotine exposure on the dopaminergic system and nicotine consumption in adulthood.

methodsMale and female mice were used for two-bottle-choice test, progressive ratio breakpoint test, immunohistochemistry, RNAscope, quantitative polymerase chain reaction, calcium imaging, and DREADD (designer receptor exclusively activated by designer drugs)-mediated chemogenic activation/inhibition experiments.

resultsNeonatal nicotine exposure potentiates drug preference in adult mice, induces alterations in calcium spike activity of midbrain neurons, and increases the number of dopamine-expressing neurons in the ventral tegmental area. Specifically, glutamatergic neurons are first primed to express transcription factor Nurr1, then acquire the dopaminergic phenotype following nicotine re-exposure in adulthood. Enhanced neuronal activity combined with Nurr1 expression is both necessary and sufficient for the nicotine-mediated neurotransmitter plasticity to occur.

conclusionsOur findings illuminate a new mechanism of neuroplasticity by which early nicotine exposure primes the reward system to display increased susceptibility to drug consumption in adulthood.

Indexed as

AnimalsDopamineDopaminergic NeuronsFemaleMaleMesencephalonMiceMice, Inbred C57BLNeuronal PlasticityNicotinePhenotypeRewardVentral Tegmental AreaDopamineNicotineDopamineNeurotransmitter-switchingNicotinePlasticityTyrosine hydroxylaseVTA

Identifiers

PMID31202491
PMCPMC7359410
OpenAlexW2941538572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.